Stents market seen reaching $15.62 billion by 2030

The global stents market is projected to grow from $11.81 billion in 2025 to $15.62 billion by 2030, driven by rising cardiovascular disease, expanding use of angioplasty, and advances in drug-eluting and bioabsorbable devices. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Stents are used to keep narrowed or blocked blood vessels open and help reduce the risk of heart attacks and related complications. - The market’s growth tracks rising cardiovascular disease rates, which continue to increase demand for angioplasty and other vessel-opening procedures. - The forecast points to more spending on device innovation, hospital capacity, and minimally invasive care.

What happened: - The Business Research Company projected the global stents market at $12.49 billion in 2026, up from $11.81 billion in 2025. - The report forecast the market will reach $15.62 billion by 2030. - The company said the market is expected to grow at a 5.8% CAGR from 2025 to 2026 and 5.7% from 2026 to 2030. - The report was published Aug. 30, 2026, from London.

The details: - The report said growth has been supported by rising coronary artery disease, better hospital infrastructure, and wider use of angioplasty. - The report said older growth limits included limited stent materials and heavy dependence on bare-metal stents. - The forecast credits future growth to drug-eluting stents, bioabsorbable stents, broader use in neurovascular and peripheral interventions, and higher R&D spending. - The report also points to an aging population with cardiovascular disease, smart technologies, and AI-assisted deployment systems as tailwinds. - The company said key trends include more minimally invasive procedures, stronger demand for customized stent designs and materials, and tighter regulation with more post-market monitoring. - In January 2025, the British Heart Foundation reported about 7.6 million people in the UK were living with heart and circulatory diseases. - The British Heart Foundation said those conditions account for nearly 27% of all UK deaths, or more than 170,000 deaths a year. - The report defined a stent as a tiny, mesh-like tube inserted into narrowed or blocked blood vessels to maintain blood flow. - The report said stents are commonly used during angioplasty to treat coronary artery disease and prevent arteries from collapsing after intervention. - The report included coverage of Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - North America held the largest market share in 2025. - Asia-Pacific is forecast to grow the fastest over the coming years. - The report also highlighted new 2026 features including market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The company offered a free sample of the report at Download a free sample of the stents market report. - The company also posted the full report at View the full stents market report.

Between the lines: - The forecast suggests the market is moving from basic metal stents toward more advanced devices with broader uses and better delivery systems. - The regional outlook implies mature demand in North America and faster adoption in Asia-Pacific as healthcare access expands. - The emphasis on regulation and monitoring signals a market where product performance and safety remain central to future growth.

What's next: - The Business Research Company expects continued growth as drug-eluting, bioabsorbable, and smart stent technologies gain traction. - The report points to further adoption of AI-assisted deployment systems and customized designs. - Market participants are likely to focus on product innovation, regulatory compliance, and post-market evidence to compete in a larger but more scrutinized market.

The bottom line: - The stents market is on a steady expansion path, with cardiovascular disease and device innovation driving demand toward $15.62 billion by 2030.